Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis

Atherosclerosis is a lipid-driven chronic inflammatory disease that is characterized by the formation and progressive growth of atherosclerotic plaques in the wall of arteries. Atherosclerosis is a major predisposing factor for stroke and heart attack. Various immune-mediated mechanisms are implicat...

Full description

Bibliographic Details
Main Authors: Natalia Kurilenko, Aliia R. Fatkhullina, Aleksandra Mazitova, Ekaterina K. Koltsova
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/2/348
_version_ 1797413187217260544
author Natalia Kurilenko
Aliia R. Fatkhullina
Aleksandra Mazitova
Ekaterina K. Koltsova
author_facet Natalia Kurilenko
Aliia R. Fatkhullina
Aleksandra Mazitova
Ekaterina K. Koltsova
author_sort Natalia Kurilenko
collection DOAJ
description Atherosclerosis is a lipid-driven chronic inflammatory disease that is characterized by the formation and progressive growth of atherosclerotic plaques in the wall of arteries. Atherosclerosis is a major predisposing factor for stroke and heart attack. Various immune-mediated mechanisms are implicated in the disease initiation and progression. Cytokines are key mediators of the crosstalk between innate and adaptive immune cells as well as non-hematopoietic cells in the aortic wall and are emerging players in the regulation of atherosclerosis. Progression of atherosclerosis is always associated with increased local and systemic levels of pro-inflammatory cytokines. The role of cytokines within atherosclerotic plaque has been extensively investigated; however, the cell-specific role of cytokine signaling, particularly the role of cytokines in the regulation of barrier tissues tightly associated with microbiota in the context of cardiovascular diseases has only recently come to light. Here, we summarize the knowledge about the function of cytokines at mucosal barriers and the interplay between cytokines, barriers, and microbiota and discuss their known and potential implications for atherosclerosis development.
first_indexed 2024-03-09T05:14:01Z
format Article
id doaj.art-775e42f8efbd4ec793aed3e1301a3bd2
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T05:14:01Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-775e42f8efbd4ec793aed3e1301a3bd22023-12-03T12:46:51ZengMDPI AGCells2073-44092021-02-0110234810.3390/cells10020348Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in AtherosclerosisNatalia Kurilenko0Aliia R. Fatkhullina1Aleksandra Mazitova2Ekaterina K. Koltsova3Department of Medicine and Department of Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USADepartment of Pathology, University of Chicago, Chicago, IL 60637, USADepartment of Medicine and Department of Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USADepartment of Medicine and Department of Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USAAtherosclerosis is a lipid-driven chronic inflammatory disease that is characterized by the formation and progressive growth of atherosclerotic plaques in the wall of arteries. Atherosclerosis is a major predisposing factor for stroke and heart attack. Various immune-mediated mechanisms are implicated in the disease initiation and progression. Cytokines are key mediators of the crosstalk between innate and adaptive immune cells as well as non-hematopoietic cells in the aortic wall and are emerging players in the regulation of atherosclerosis. Progression of atherosclerosis is always associated with increased local and systemic levels of pro-inflammatory cytokines. The role of cytokines within atherosclerotic plaque has been extensively investigated; however, the cell-specific role of cytokine signaling, particularly the role of cytokines in the regulation of barrier tissues tightly associated with microbiota in the context of cardiovascular diseases has only recently come to light. Here, we summarize the knowledge about the function of cytokines at mucosal barriers and the interplay between cytokines, barriers, and microbiota and discuss their known and potential implications for atherosclerosis development.https://www.mdpi.com/2073-4409/10/2/348cytokinesatherosclerosismicrobiotabarrier tissueinflammation
spellingShingle Natalia Kurilenko
Aliia R. Fatkhullina
Aleksandra Mazitova
Ekaterina K. Koltsova
Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
Cells
cytokines
atherosclerosis
microbiota
barrier tissue
inflammation
title Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
title_full Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
title_fullStr Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
title_full_unstemmed Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
title_short Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
title_sort act locally act globally microbiota barriers and cytokines in atherosclerosis
topic cytokines
atherosclerosis
microbiota
barrier tissue
inflammation
url https://www.mdpi.com/2073-4409/10/2/348
work_keys_str_mv AT nataliakurilenko actlocallyactgloballymicrobiotabarriersandcytokinesinatherosclerosis
AT aliiarfatkhullina actlocallyactgloballymicrobiotabarriersandcytokinesinatherosclerosis
AT aleksandramazitova actlocallyactgloballymicrobiotabarriersandcytokinesinatherosclerosis
AT ekaterinakkoltsova actlocallyactgloballymicrobiotabarriersandcytokinesinatherosclerosis